相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。m6A reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin
Diefei Liang et al.
AUTOPHAGY (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
N6-methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305
Xi Rao et al.
IUBMB LIFE (2021)
Depletion of m6A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin
Siyun Gao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Genetic variants in m6A modification core genes are associated with glioma risk in Chinese children
Jing He et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
The construction and validation of an RNA binding protein-related prognostic model for bladder cancer
Fengxia Chen et al.
BMC CANCER (2021)
METTL3 regulates heterochromatin in mouse embryonic stem cells
Wenqi Xu et al.
NATURE (2021)
The RNA m6A reader YTHDC1 silences retrotransposons and guards ES cell identity
Jiadong Liu et al.
NATURE (2021)
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
Shanshan Wang et al.
FRONTIERS IN GENETICS (2021)
m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer
Huaying Zhao et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
Liqi Shu et al.
CELLS (2021)
The RNA Binding Proteins YTHDC1 and FMRP Regulate the Nuclear Export of N6-Methyladenosine-Modified Hepatitis B Virus Transcripts and Affect the Viral Life Cycle
Geon-Woo Kim et al.
JOURNAL OF VIROLOGY (2021)
N-6-Methyladenosine (m(6)A) readers are dysregulated in renal cell carcinoma
Felix von Hagen et al.
MOLECULAR CARCINOGENESIS (2021)
Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos
Chuan Chen et al.
PROTEIN & CELL (2021)
Comprehensive Analysis of the Prognostic Role and Mutational Characteristics of m6A-Related Genes in Lung Squamous Cell Carcinoma
Chang Gu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer
Jian Ma et al.
AGING-US (2021)
A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication
Yue Sheng et al.
BLOOD (2021)
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation
Yuanming Cheng et al.
CANCER CELL (2021)
YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect
Yichao Hou et al.
CELL DEATH AND DIFFERENTIATION (2021)
Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration
Kuan Hu et al.
DISEASE MARKERS (2021)
Epitranscriptomic addition of m6A regulates HIV-1 RNA stability and alternative splicing
Kevin Tsai et al.
GENES & DEVELOPMENT (2021)
N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer
Zhenchuan Liu et al.
MOLECULAR CANCER (2021)
Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation
Joo-Hyung Lee et al.
MOLECULAR CELL (2021)
EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties
Kailing Zhou et al.
CELL DEATH & DISEASE (2021)
m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression
Dawei Rong et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer
Kun Fang et al.
FRONTIERS IN GENETICS (2021)
m6A RNA methylation regulators contribute to malignant progression in rectal cancer
Jinfu Zhuang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu et al.
NUCLEIC ACIDS RESEARCH (2020)
N6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription
Jun Liu et al.
SCIENCE (2020)
Modulation of circRNA Metabolism by m6A Modification
Gaia Di Timoteo et al.
CELL REPORTS (2020)
Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy
Aishika Datta et al.
TRANSLATIONAL STROKE RESEARCH (2020)
The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang et al.
MOLECULAR CANCER (2020)
N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2
Yuan Li et al.
NATURE GENETICS (2020)
Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies
Zhen-Hua Chen et al.
CELL DEATH & DISEASE (2020)
m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
Fangwei Li et al.
FRONTIERS IN GENETICS (2020)
YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis
Guoqiang Chang et al.
CANCER CELL (2020)
YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA
Zhaolong Zhang et al.
CELL DEATH & DISEASE (2020)
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
Jiangfeng Li et al.
MOLECULAR CANCER (2020)
Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
Yufeng Shi et al.
NATURE (2019)
N6-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma
Fuxi Li et al.
CANCER RESEARCH (2019)
The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing
Hayley J. Luxton et al.
CANCERS (2019)
N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis
Ri-Xin Chen et al.
NATURE COMMUNICATIONS (2019)
Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA dataoase
Jingcheng Zhou et al.
AGING-US (2019)
Dynamic m6A modification regulates local translation of mRNA in axons
Jun Yu et al.
NUCLEIC ACIDS RESEARCH (2018)
Glioma epigenetics: From subclassification to novel treatment options
Olga Gusyatiner et al.
SEMINARS IN CANCER BIOLOGY (2018)
HIV-Associated Cancers and Related Diseases
Robert Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development
Seth D. Kasowitz et al.
PLOS GENETICS (2018)
m6A facilitates hippocampus-dependent learning and memory through YTHDF1
Hailing Shi et al.
NATURE (2018)
Ythdf2-mediated m6A mRNA clearance modulates neural development in mice
Miaomiao Li et al.
GENOME BIOLOGY (2018)
Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N6-Adenosine Methylation To Promote Lytic Replication
Fengchun Ye et al.
JOURNAL OF VIROLOGY (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
MicroRNAs control mRNA fate by compartmentalization based on 3′ UTR length in male germ cells
Ying Zhang et al.
GENOME BIOLOGY (2017)
m6A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination
Irmgard U. Haussmann et al.
NATURE (2016)
m6A modulates neuronal functions and sex determination in Drosophila
Tina Lence et al.
NATURE (2016)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
Contemporary definitions and classification of the cardiomyopathies - An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; And Council on Epidemiology and Prevention
BJ Maron et al.
CIRCULATION (2006)